Vera Therapeutics, Inc. (28)
Browse by Contract Category
Contracts
-
Description of Common Stock of the Registrant
(Filed With SEC on March 28, 2022)
-
Amendment No. 1 to License Agreement between Novartis International Pharmaceutical AG and Amplyx Pharmaceuticals, Inc. dated September 24, 2019
(Filed With SEC on February 7, 2022)
-
Offer Letter, by and between the Company and Sean P. Grant, dated May 30, 2021
(Filed With SEC on July 14, 2021)
-
Form of Indemnification Agreement by and between the Registrant and its directors and executive officers
(Filed With SEC on May 10, 2021)
-
Vera Therapeutics, Inc. 2021 Non-Employee Director Compensation Policy
(Filed With SEC on May 10, 2021)
-
License Agreement between Novartis International Pharmaceutical AG and Amplyx Pharmaceuticals, Inc. dated August 26, 2019
(Filed With SEC on February 7, 2022)
-
Asset Purchase Agreement between the Registrant and Amplyx Pharmaceuticals, Inc. dated December 16, 2021
(Filed With SEC on February 7, 2022)
-
Loan and Security Agreement between the Registrant and Oxford Finance LLC, dated December 17, 2021
(Filed With SEC on February 7, 2022)
-
Form of Underwriting Agreement
(Filed With SEC on February 7, 2022)
-
Vera Therapeutics, Inc. 2021 Employee Stock Purchase Plan
(Filed With SEC on May 10, 2021)
-
Amended and Restated Offer Letter by and between the Registrant and Celia Lin, M.D., dated May 7, 2021
(Filed With SEC on May 10, 2021)
-
Amended and Restated Offer Letter by and between the Registrant and Joanne Curley, Ph.D., dated May 7, 2021
(Filed With SEC on May 10, 2021)
-
Amended and Restated Offer Letter by and between the Registrant and Marshall Fordyce, M.D., dated May 7, 2021
(Filed With SEC on May 10, 2021)
-
Forms of Restricted Stock Unit Grant Notice and Award Agreement under the Vera Therapeutics, Inc. 2021 Equity Incentive Plan
(Filed With SEC on May 10, 2021)
-
Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the Vera Therapeutics, Inc. 2021 Equity Incentive Plan
(Filed With SEC on May 10, 2021)
-
Vera Therapeutics, Inc. 2021 Equity Incentive Plan
(Filed With SEC on May 10, 2021)
-
Form of Class A Common Stock Certificate
(Filed With SEC on May 10, 2021)
-
Form of Underwriting Agreement
(Filed With SEC on May 10, 2021)
-
Vera Therapeutics, Inc. 2017 Equity Incentive Plan
(Filed With SEC on April 23, 2021)
-
License Agreement by and between the Registrant and Ares Trading S.A., dated as of October 29, 2020
(Filed With SEC on April 23, 2021)
-
Separation Agreement by and between the Registrant and Allen Ebens, Ph.D., dated September 24, 2020
(Filed With SEC on April 23, 2021)
-
Offer Letter by and between the Registrant and Allen Ebens, Ph.D., dated July 26, 2018
(Filed With SEC on April 23, 2021)
-
Confidential Consulting Agreement by and between the Registrant and FLG Partners, LLC, dated March 15, 2020
(Filed With SEC on April 23, 2021)
-
Amendment to Employment Agreement by and between the Registrant and Joanne Curley, Ph.D., dated September 3, 2020
(Filed With SEC on April 23, 2021)
-
Offer Letter by and between the Registrant and Joanne Curley, Ph.D., dated February 5, 2020
(Filed With SEC on April 23, 2021)
-
Amended and Restated Offer Letter by and between the Registrant and Marshall Fordyce, M.D., dated December 22, 2020
(Filed With SEC on April 23, 2021)
-
Forms of Grant Notice, Stock Option Agreement and Notice of Exercise under the Vera Therapeutics, Inc. 2017 Equity Incentive Plan
(Filed With SEC on April 23, 2021)
-
Second Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated October 29, 2020
(Filed With SEC on April 23, 2021)